about
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF ...
Read More
1.48
0.05
(3.50%)
992.0K
XNAS Volume
XNAS 04 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Erasca Inc is on 09 Sep 2025 for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Neutral
Erasca Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..